LeMaitre Vascular Current Ratio 2007-2019 | LMAT

LeMaitre Vascular current ratio from 2007 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
LeMaitre Vascular Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.10B $0.02B 5.16
2019-06-30 $0.10B $0.02B 5.63
2019-03-31 $0.10B $0.02B 4.92
2018-12-31 $0.09B $0.02B 4.76
2018-09-30 $0.09B $0.02B 5.93
2018-06-30 $0.09B $0.01B 7.04
2018-03-31 $0.08B $0.01B 6.65
2017-12-31 $0.08B $0.01B 6.09
2017-09-30 $0.08B $0.01B 6.25
2017-06-30 $0.07B $0.01B 7.25
2017-03-31 $0.06B $0.01B 5.81
2016-12-31 $0.06B $0.01B 5.63
2016-09-30 $0.07B $0.01B 5.66
2016-06-30 $0.06B $0.01B 6.16
2016-03-31 $0.06B $0.01B 5.88
2015-12-31 $0.06B $0.01B 5.61
2015-09-30 $0.05B $0.01B 6.11
2015-06-30 $0.05B $0.01B 5.45
2015-03-31 $0.05B $0.01B 5.70
2014-12-31 $0.05B $0.01B 4.84
2014-09-30 $0.05B $0.01B 3.93
2014-06-30 $0.05B $0.01B 5.88
2014-03-31 $0.04B $0.01B 4.63
2013-12-31 $0.04B $0.01B 4.08
2013-09-30 $0.04B $0.01B 4.20
2013-06-30 $0.04B $0.01B 5.21
2013-03-31 $0.04B $0.01B 4.92
2012-12-31 $0.04B $0.01B 4.66
2012-09-30 $0.04B $0.01B 5.15
2012-06-30 $0.04B $0.01B 5.86
2012-03-31 $0.04B $0.01B 6.30
2011-12-31 $0.04B $0.01B 6.07
2011-09-30 $0.04B $0.01B 4.35
2011-06-30 $0.04B $0.01B 4.98
2011-03-31 $0.04B $0.01B 5.00
2010-12-31 $0.04B $0.01B 4.13
2010-09-30 $0.04B $0.01B 5.65
2010-06-30 $0.04B $0.01B 6.15
2010-03-31 $0.04B $0.01B 6.39
2009-12-31 $0.04B $0.01B 6.04
2009-09-30 $0.04B $0.01B 5.60
2009-06-30 $0.04B $0.01B 5.79
2009-03-31 $0.03B $0.01B 6.45
2008-12-31 $0.04B $0.01B 5.35
2008-09-30 $0.04B $0.01B 5.55
2008-06-30 $0.04B $0.01B 4.43
2008-03-31 $0.04B $0.01B 4.56
2007-12-31 $0.04B $0.01B 4.16
2007-09-30 $0.04B $0.01B 6.10
2007-06-30 $0.04B $0.01B 8.77
2007-03-31 $0.04B $0.01B 8.72
2006-12-31 $0.04B $0.01B 8.13
2006-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.707B $0.106B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $152.034B 27.73
Medtronic (MDT) Ireland $150.632B 20.81
Stryker (SYK) United States $74.735B 25.13
Boston Scientific (BSX) United States $62.262B 29.39
Baxter (BAX) United States $42.637B 25.85
Essilor Luxottica (ESLOY) France $33.791B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.320B 19.02
Terumo (TRUMY) Japan $26.378B 32.92
Lonza Group Ag (LZAGY) Switzerland $25.349B 0.00
Coloplast (CLPBY) Denmark $25.034B 38.63
ResMed (RMD) United States $21.891B 40.38
Smith & Nephew SNATS (SNN) United Kingdom $19.633B 0.00
Sunny Optical Technology (SNPTF) China $19.217B 0.00
Bio-Rad Laboratories (BIO) United States $10.857B 52.11
Insulet (PODD) United States $10.712B 509.65
William Demant Holdings (WILYY) Denmark $7.626B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
Perrigo (PRGO) Ireland $7.422B 13.84
Canopy Growth (CGC) Canada $7.365B 0.00
Hill-Rom Holdings (HRC) United States $7.342B 21.65
Haemonetics (HAE) United States $5.938B 40.13
Shandong Weigao Medical Polymer (SHWGF) China $5.472B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.844B 30.27
ICU Medical (ICUI) United States $3.765B 24.54
Neogen (NEOG) United States $3.625B 60.65
GW Pharmaceuticals (GWPH) United Kingdom $3.265B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.174B 0.00
Quidel (QDEL) United States $2.995B 28.42
Aurora Cannabis (ACB) Canada $2.833B 0.00
Agios Pharmaceuticals (AGIO) United States $2.691B 0.00
National Vision Holdings (EYE) United States $2.513B 56.71
Cardiovascular Systems (CSII) United States $1.557B 0.00
Aphria (APHA) $1.326B 0.00
InMode (INMD) Israel $1.245B 0.00
AtriCure (ATRC) United States $1.217B 0.00
VAREX IMAGING (VREX) United States $1.208B 24.20
Phibro Animal Health (PAHC) United States $0.994B 18.61
TG Therapeutics (TGTX) United States $0.935B 0.00
NanoString Technologies (NSTG) United States $0.916B 0.00
Lantheus Holdings (LNTH) United States $0.810B 20.23
Eagle Pharmaceuticals (EGRX) United States $0.809B 30.96
Quanterix (QTRX) United States $0.698B 0.00
PetIQ (PETQ) United States $0.694B 16.94
Omeros (OMER) United States $0.657B 0.00
HEXO (HEXO) $0.573B 0.00
Cerus (CERS) United States $0.566B 0.00
Surmodics (SRDX) United States $0.549B 57.11
MacroGenics (MGNX) United States $0.505B 0.00
OraSure Technologies (OSUR) United States $0.491B 29.48
Meridian Bioscience (VIVO) United States $0.418B 14.38
Organigram Holdings (OGI) Canada $0.401B 0.00
Utah Medical Products (UTMD) United States $0.395B 28.63
Owens & Minor (OMI) United States $0.387B 14.30
BioLife Solutions (BLFS) United States $0.317B 129.08
Zynex (ZYXI) United States $0.283B 32.04
Neptune Wellness Solutions (NEPT) Canada $0.281B 0.00
Bovie Medical (APYX) United States $0.275B 0.00
United Health Products (UEEC) United States $0.254B 0.00
Vapotherm (VAPO) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.239B 25.14
Repro-Med Systems (KRMD) United States $0.234B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.170B 0.00
Liberty Health Sciences (LHSIF) Canada $0.170B 0.00
InfuSystems Holdings (INFU) United States $0.164B 824.00
Female Health (VERU) United States $0.156B 0.00
Rockwell Medical (RMTI) United States $0.145B 0.00
MTech Acquisition (KERN) United States $0.136B 0.00
Fonar (FONR) United States $0.131B 9.20
Cytosorbents (CTSO) United States $0.130B 0.00
Chimerix (CMRX) United States $0.118B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
United-Guardian (UG) United States $0.091B 23.03
Chembio Diagnostics (CEMI) United States $0.078B 0.00
Nephros (NEPH) United States $0.067B 0.00
MRI Interventions (MRIC) United States $0.062B 0.00
Surface Oncology (SURF) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00